trial

Schizophrenia and PTSD Project: Health, Interventions, and Risk/Resilience Evaluation(SAPPHIRE Study)

NCTId NCT00560677
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Unknown
Enrollment 400 (estimated)
Sponsored by Durham VA Medical Center
Primary completion 2023-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
400 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2007-03
Primary completion
2023-12
Eligibility
ALL · 18 Years · 72 Years

Interventions & indications

Drugs
—

Sponsors

Durham VA Medical CenterLead Sponsor

Investigators

1
Christine E Marx, MD, MAPrincipal Investigator

Sites

1 total
Durham, United States

Facts & assertions

4 sourced
Enrollment
400
Phase
NA
Primary Completion Date
2023-12
Status
UNKNOWN
relationships
The graph out of here
lead_sponsor
Durham VA Medical Center
company
indication
Schizophrenia
indication
Schizophrenia
indication
PTSD
indication
investigator
Christine E Marx, MD, MA
person